This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (518) Web-based and Mobile Health Interventions (3193) Digital Mental Health Interventions, e-Mental Health and Cyberpsychology (1445) mHealth for Treatment Adherence (390) Depression and Mood Disorders; Suicide Prevention (1315) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1358)

Published on in Vol 13 (2024)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/56960, first published .
Evaluating the Efficacy of a Digital Therapeutic (CT-152) as an Adjunct to Antidepressant Treatment in Adults With Major Depressive Disorder: Protocol for the MIRAI Remote Study

Evaluating the Efficacy of a Digital Therapeutic (CT-152) as an Adjunct to Antidepressant Treatment in Adults With Major Depressive Disorder: Protocol for the MIRAI Remote Study

Evaluating the Efficacy of a Digital Therapeutic (CT-152) as an Adjunct to Antidepressant Treatment in Adults With Major Depressive Disorder: Protocol for the MIRAI Remote Study

Authors of this article:

Brian Rothman1 Author Orcid Image ;   Mary Slomkowski1 Author Orcid Image ;   Austin Speier2 Author Orcid Image ;   A John Rush3, 4 Author Orcid Image ;   Madhukar H Trivedi5, 6 Author Orcid Image ;   Erica Lawson1 Author Orcid Image ;   Michael Fahmy1 Author Orcid Image ;   Daniel Carpenter7 Author Orcid Image ;   Dalei Chen1 Author Orcid Image ;   Ainslie Forbes1 Author Orcid Image
Article Authors Cited by Tweetations Metrics

Brian Rothman   1 , PhD ;   Mary Slomkowski   1 , PharmD ;   Austin Speier   2 , BA ;   A John Rush   3, 4 , MD ;   Madhukar H Trivedi   5, 6 , MD ;   Erica Lawson   1 , BS ;   Michael Fahmy   1 , MS ;   Daniel Carpenter   7 , PhD ;   Dalei Chen   1 , PhD ;   Ainslie Forbes   1 , PhD

1 Otsuka Pharmaceutical Development & Commercialization, Inc, Princeton, NJ, United States

2 Click Therapeutics, Inc, New York, NY, United States

3 School of Medicine, Duke University, Durham, NC, United States

4 Duke-National University of Singapore Medical School, Singapore, Singapore

5 Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, United States

6 O’Donnell Brain Institute, University of Texas Southwestern Medical Center, Dallas, TX, United States

7 Otsuka Precision Health, Inc, Princeton, NJ, United States

Corresponding Author: